Morningstar Investment Services LLC Has $4.88 Million Holdings in Becton, Dickinson and Company (NYSE:BDX)

Morningstar Investment Services LLC cut its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 50.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,282 shares of the medical instruments supplier's stock after selling 21,693 shares during the period. Becton, Dickinson and Company accounts for about 0.9% of Morningstar Investment Services LLC's investment portfolio, making the stock its 26th biggest position. Morningstar Investment Services LLC's holdings in Becton, Dickinson and Company were worth $4,875,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Hillsdale Investment Management Inc. lifted its stake in shares of Becton, Dickinson and Company by 1.7% during the 4th quarter. Hillsdale Investment Management Inc. now owns 3,060 shares of the medical instruments supplier's stock worth $694,000 after purchasing an additional 50 shares during the last quarter. Northcape Wealth Management LLC boosted its stake in shares of Becton, Dickinson and Company by 0.5% in the first quarter. Northcape Wealth Management LLC now owns 9,814 shares of the medical instruments supplier's stock worth $2,248,000 after buying an additional 51 shares during the last quarter. Alpha Omega Wealth Management LLC boosted its position in Becton, Dickinson and Company by 5.7% during the first quarter. Alpha Omega Wealth Management LLC now owns 984 shares of the medical instruments supplier's stock worth $225,000 after purchasing an additional 53 shares in the last quarter. Brady Family Wealth LLC lifted its position in shares of Becton, Dickinson and Company by 1.2% in the first quarter. Brady Family Wealth LLC now owns 4,317 shares of the medical instruments supplier's stock valued at $989,000 after acquiring an additional 53 shares in the last quarter. Finally, Diversified Trust Co increased its holdings in shares of Becton, Dickinson and Company by 4.7% in the first quarter. Diversified Trust Co now owns 1,188 shares of the medical instruments supplier's stock valued at $272,000 after purchasing an additional 53 shares during the last quarter. 86.97% of the stock is owned by institutional investors.

Becton, Dickinson and Company Stock Performance

NYSE BDX traded down $1.54 during trading hours on Monday, reaching $177.31. The company's stock had a trading volume of 1,582,749 shares, compared to its average volume of 2,149,122. The company has a current ratio of 1.13, a quick ratio of 0.64 and a debt-to-equity ratio of 0.70. The business has a 50-day simple moving average of $173.51 and a 200 day simple moving average of $204.06. Becton, Dickinson and Company has a 52 week low of $163.33 and a 52 week high of $251.99. The stock has a market cap of $50.82 billion, a PE ratio of 33.88, a PEG ratio of 1.35 and a beta of 0.25.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $3.35 EPS for the quarter, beating analysts' consensus estimates of $3.28 by $0.07. Becton, Dickinson and Company had a net margin of 7.28% and a return on equity of 15.99%. The business had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.35 billion. During the same quarter last year, the business earned $3.17 earnings per share. The business's revenue for the quarter was up 4.5% on a year-over-year basis. Equities research analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.

Becton, Dickinson and Company Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 9th were paid a $1.04 dividend. This represents a $4.16 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date was Monday, June 9th. Becton, Dickinson and Company's dividend payout ratio is 79.39%.

Insider Buying and Selling

In other Becton, Dickinson and Company news, EVP David Shan sold 1,166 shares of Becton, Dickinson and Company stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $171.19, for a total transaction of $199,607.54. Following the completion of the sale, the executive vice president owned 4,575 shares of the company's stock, valued at $783,194.25. This trade represents a 20.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.36% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on BDX shares. The Goldman Sachs Group cut Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $192.00 price objective for the company. in a research note on Friday, May 2nd. Wells Fargo & Company downgraded Becton, Dickinson and Company from an "overweight" rating to an "equal weight" rating in a report on Thursday, May 1st. Raymond James Financial downgraded Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a report on Friday, May 2nd. Citigroup downgraded Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating and dropped their price target for the stock from $217.00 to $185.00 in a research note on Thursday, May 22nd. Finally, Piper Sandler cut Becton, Dickinson and Company from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $260.00 to $185.00 in a research report on Friday, May 2nd. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, Becton, Dickinson and Company currently has an average rating of "Hold" and an average price target of $219.22.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.